REFERENCES
- Heller W., Pugh T. L.. 1960. Steric stabilization of collidal solutions by adsorption of flexible macromolecules. J. Polym. Sci.. 203–217
- Jaeschke H., Werner C., Wendel A.. 1987. Disposition and Hepatoprotection by phosphatidyl Choline liposomes in mouse liver. Chem. Biol. Interact.. 64: 127–137. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Karison P.. 1984. Kurzes Lehrbuch der Biochemic für Mediziner and Naturwissenschaftler. Thieme Verlag. 134–141
- Miguez M. P., Anundi I., Sainz-Pardo L. A., Lindros K. O.. 1994. Hepatoprotective mechanism of Silymarin: No evidence for involvement of Cytochrome P450 2E1. Chem. Biol. Interact.. 91: 51–63. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Miyata I., Miyamoto H., Yonese M.. 1996. Effect of chain lengths of n-Alcohol on the formation of Single-phase microemulsions in n-Heptane/n-Alcohol/sodium Dodecyl Sulfate/water systems. Chem. Pharm. Bull.. 1049–1055
- Mizushima Y., Hamano T., Yokoyama K.. 1982. Use of lipid emulsions as a novel carrier for consticosteroids. J. Pharm. Pharmacol.. 34: 49–50. [PUBMED], [INFOTRIEVE]
- Mizushima Y., Wada Y., Etoh Y., Watanabe K.. 1983. Antiinflammatory effect of indomethacin ester incorporated in lipid microsphere. J. Pharm. Pharmacol. 35: 398–399. [PUBMED], [INFOTRIEVE]
- Moreno M. A., Frutos P., Ballesteros M. P.. 2001. Lyophilized lecithin based oil-in-water microemulsions as new and low toxic delivery system for Amphotericin B. Pharm. Res.. 18: 344–351. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Wellington K., Jarvis B.. 2001. Silymarin: A review of its clinical properties in the management of hepatic disorders. Bio. Drugs.. 15: 465–489
- Yamaguchi T.. 1994. Lipid microspheres for drug delivery from the pharmaceutical viewpoint. Crit. Rev. Ther. Drug Carrier Sys.. 11: 215–229